AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Dec 27 2021
News
Experts Warn Pfizer Antiviral Pills May Pose Risks With Other Medications
Experts warn that despite the first antiviral pills for COVID-19 promising protection for those at risk of severe disease, Pfizer's or Merck's new medications may not be safe for everyone, NBC News reported over the weekend.
One of the two drugs in Pfizer's Paxlovid antiviral cocktail could cause severe or life-threatening interactions with commonly used medications, including statins,
Newsmax (News)Aug 18 2020
Data
What Is It Like to Work With Androids?
Last summer, the €16 billion science and technology company Merck KGaA, Darmstadt, Germany, brought in an HR specialist named Elenoide to handle employee development questions at HQ.
Brought, not hired. Elenoide is an android, a carefully crafted work of robotics capable of some of the most advanced AI known to HR tech.
Elenoide isn't meant to replace or even supplement the
GallupDec 27 2021
News
Pfizer antiviral pills may be risky with other medications
As the omicron surge pummels a pandemic-weary nation, the first antiviral pills for Covid-19 promise desperately needed protection for people at risk of severe disease. However, many people prescribed Pfizer’s or Merck’s new medications will require careful monitoring by doctors and pharmacists, and the antivirals may not be safe for everyone, experts caution.
The Food and Drug
NBC News (Online)Mar 21 2022
News
Doctors finding hurdles to using pills to treat COVID-19
High-risk COVID-19 patients now have new treatments they can take at home to stay out of the hospital — if doctors get the pills to them fast enough.
Health systems around the country are rushing out same-day prescription deliveries. Some clinics have started testing and treating patients in one visit, an initiative that President Joe Biden’s administration recently touted.
The
Associated PressAug 15 2017
News
Charlottesville: CEOs quit Trump council over response to violence
Bosses from Intel, Merck and Under Armour distance themselves from administration after president’s reluctance to denounce white nationalists
The GuardianFeb 07 2022
News
Pharmacies feel stiffed on COVID pill payments
Some pharmacies are getting paid as little as $1 to dispense the COVID antiviral pills made by Pfizer and Merck.
Why it matters: Most pharmacies want to offer the drugs, especially the one from Pfizer that drastically cuts the odds of hospitalization and death. But low payments could hurt Americans' ability to access the pills in some areas if pharmacies decide they can't afford to
AxiosNov 16 2021
News
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries
Pfizer announced a deal on Tuesday to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer nations that are home to more than half of the world’s population.
The agreement follows a similar arrangement negotiated by Merck last month, and together the deals have the potential to vastly expand global production of two simple antiviral pills that could
New York Times (News)Nov 04 2021
News
First pill to treat Covid gets approval in UK
The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator.
The tablet - molnupiravir - will be given twice a day to vulnerable patients recently diagnosed with the disease.
In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalisation or death by about half.
Health Secretary Sajid Javid said the
BBC NewsMar 02 2021
News
Biden says U.S. will have enough vaccines for 300 million adults by end of May
President Biden on Tuesday said that ramped-up coronavirus vaccine production will provide enough doses for 300 million Americans by the end May.
Why it matters: That's two months sooner than Biden's previous promise of enough vaccines for all American adults by the end of July.
The accelerated timeline also comes on the heels of pharmaceutical manufacturer Merck teaming up with
AxiosNov 05 2021
News
Covid: Pfizer says antiviral pill 89% effective in high risk cases
An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug - Paxlovid - is intended for use soon after symptoms develop in people at high risk of severe disease.
It comes a day after the UK medicines regulator approved a similar treatment from Merck Sharp
BBC News